Browse studies

Find your next paid study

4 recruiting studies matching your filters

Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults

The main aim of this study is to assess real-world effectiveness of nemolizumab in Prurigo nodularis (PN) as measured by investigator and patient reported outc…

Prurigo Nodularis

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Galderma R&DNCT06988618

Phase 2

Evaluating the Efficacy and Speed of Response of Lebrikizumab in High-Burden Prurigo Nodularis Patients: A 24-Week Study

The purpose of this study is to evaluate the effectiveness of lebrikizumab in treating adults with moderate-to-severe Prurigo Nodularis (PN).

Prurigo Nodularis (PN)

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of Maryland, BaltimoreNCT07620561

Phase 2

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis

Evaluate the efficacy and safety of ICP-332 in participants with Prurigo Nodularis (PN)

Prurigo Nodularis (PN)

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Beijing InnoCare Pharma Tech Co., Ltd.NCT07236099

Phase 3

A Multicenter Open-label Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis

This is a Phase 3, multicenter, open-label, pharmacokinetics (PK)/safety study. The study consists of 3 periods: * Screening period: 2 to 4 weeks. * Treatmen…

Prurigo Nodularis

Estimated

~$50 – $2,250

Actual pay is set by the research site.

SanofiNCT06293053